Intriguingly, loss of 53BP1, observed in 20% of PARPi-resistant breast cancer PDXs, mechanistically restores HR by allowing the access of DNA nucleases (Cruz et al. 2018; Waks et al. 2020). The gene discussed is TP53BP1; the disease is breast carcinoma.